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Abstract
Background: Assessment of blood pressure values and early diagnosis of hypertension are especially important in 
high-risk group, including patients in preoperative and postoperative period. The aim of the current study was the 
assessment of blood pressure values and prevalence of hypertension in patients undergoing elective hip replacement 
surgery — an orthopedic procedure associated with one of the highest cardiovascular complication rate. 
Material and methods: Two hundred and eighty-four consecutive patients admitted for elective hip replacement surgery 
were screened for arterial hypertension. All patients had their medical records reviewed for prior diagnosis and had their 
blood pressure measured on admission by a qualified physician prior to the procedure, according to the current guidelines. 
Results: The mean age of the study population was 62.2 ± 13.9 years and 42.7% of the patients were male. The body mass 
index (BMI) in the study population was 27.0 ± 4.2 kg/m2. Fifty-eight point two percent of patients were diagnosed with 
arterial hypertension previously. Mean blood pressure values on admission for systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) were 134.5 ± 20.4 and 78.6 ± 13.1 mm Hg, respectively. In 43.2% of patients, the on admission 
blood pressure values exceeded the threshold of ≥ 140 and/or 90 mm Hg. Arterial hypertension was diagnosed de novo in  
33 (15.0%) patients. Patients with the disease were older (67.5 ± 12.3 vs. 54.4 ± 13.9 years; p < 0.0001), and had higher 
BMI (27.6 ± 4.3 vs. 26.2 ± 3.8 kg/m2; p = 0.05) than patients without the diagnosed disease. Diabetes mellitus was more 
often found in hypertensive patients (13.3% vs. 3.3%; p = 0.02), they also more often had history of myocardial infarction  
(p = 0.02), stable coronary artery disease (p = 0.001) and heart failure (p = 0.006) compared to patients without the diagnosis.
Conclusions: The majority of patients scheduled for elective hip replacement surgery is diagnosed with arterial 
hypertension. The disease is also diagnosed de novo in 15% of these patients. Screening for arterial hypertension is 
important in this group of patients and can potentially reduce the complication rates of the hip replacement surgery.
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Background
Arterial hypertension is one of the most prevalent 
chronic diseases [1]. The comparison of results of 
NATPOL 2011 and NATPOL demonstrate that in 
Poland the number of people suffering from arte-
rial hypertension is 2% higher than a decade ago. 
Currently, approximately 32% of adult Poles (10.5 
million patients, including 9.5 million aged 18–79 
years and almost 1 million patients over 80 years) 
suffer from arterial hypertension. As many as 30% 
of this population is not aware of the fact that they 
are afflicted with the disease and 9% have recognized, 
but untreated hypertension [2].
The results of large prospective epidemiological 
studies clearly indicate that hypertension is one of 
the most important risk factors for cardiovascular 
diseases such as coronary artery disease, heart failure, 
or stroke [3]. Moreover, arterial hypertension is re-
sponsible for considerable morbidity, mortality, and 
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disability, not only in Poland but also across the Europe 
and the United States [4]. Even the “high-normal” 
blood pressure values, still within the normal range, 
have been linked with a higher incidence and severity 
of various cardiovascular disease risk factors such as 
obesity, dyslipidemia or glucose intolerance [5].
Assessment of blood pressure values and early 
dia gnosis of hypertension is especially important in 
high-risk group, including patients in preoperative 
and postoperative period. Hypertension correlates 
with higher perioperative risk leading to severe and 
minor cardiovascular complications [6]. The aim of 
the current study was the assessment of blood pres-
sure values and prevalence of hypertension in pa-
tients undergoing elective hip replacement surgery 
— an orthopedic procedure associated with one of 
the highest cardiovascular complication rate.
Material and methods
We performed an observational cohort study in 
order to establish the prevalence of arterial hyper-
tension in consecutive Polish patients undergoing 
total hip replacement surgery in a tertiary University 
Hospital. The study was conducted with respect to 
the Declaration of Helsinki and an approval form 
the Ethics Committee by the Medical University of 
Warsaw was obtained before the beginning of the 
study. Written, informed consent was obtained from 
every study participant prior to the study enrolment.
The study cohort consisted of 284 consecutive pa-
tients who were hospitalized in a high-volume tertia-
ry university orthopedic clinic for total hip replace-
ment surgery between 2009 and 2013. All patients 
were qualified for the surgery procedure following 
current orthopedic criteria. The study population 
consisted of patients in whom the operation was 
successfully performed, and in whom the medical 
records allowed valid assessment of blood pressure 
values and current medical treatment.
Exclusion criteria were: age < 18 or ≥ 75 years, 
prior hip homolateral hip replacement surgery, stroke 
or decompensation of heart failure within the last 
six months and absence of written informed con-
sent. Registry was screened to identify all patients 
who received one or more elective primary total hip 
or knee replacements in the study period. Patients 
treated with non-elective hip arthroplasty for hip 
fracture were excluded. For patients who underwent 
more than one operative procedure during the study 
period, only the first procedure was considered; thus, 
only one operative episode was examined for each 
patient.
Data on demographics, lifestyle, comorbidity 
and cardiovascular risk factors were obtained. De-
mographic variables analyzed included age and sex. 
Comorbidities studied included presence or absence 
of heart failure, diabetes mellitus, stroke or TIA epi-
sodes, myocardial infarction episodes, peripheral ar-
tery disease, dyslipidemia, coronary artery disease, 
important valvular defect, asthma, chronic obstruc-
tive pulmonary disease, CABG, PCI, cardiac pace-
maker implanted. All patients were also screened for 
other classical and non-classical cardiovascular risk 
factors including diabetes mellitus, dyslipidemia, or 
history of cardiovascular disease. Diagnosis of all 
factors was made based on eligible medical records, 
taking prescription drugs applicable for the respec-
tive disease (i.e. hypoglycemic agents for diabetes), 
or as a de novo diagnosis according to the current 
diagnostic criteria.
All study participants were screened for arterial 
hypertension. Patients had their blood pressure mea-
sured on admission by a qualified physician prior to 
the surgery procedure. Diagnosis of arterial hyper-
tension was made when office blood pressure were 
equal or exceeded the values of 140 for systolic blood 
pressure (SBP) and/or 90 for diastolic blood pres-
sure (DBP). The number of required measurements, 
measure techniques and settings were in accordance 
with the current guidelines for arterial hypertension 
diagnosis and management of the ESC and Europe-
an Society of Hypertension. The diagnosis was also 
made were there were eligible medical records avail-
able on previous diagnosis of arterial hypertension or 
taking prescription hypotensive agents.
Statistical analysis was performed using the SAS 
software version 8.02 (SAS Institute, Inc., Cary, NC, 
USA). Continuous data are presented as mean ± 
standard deviation (SD) and were compared using 
the Mann-Whitney test or Student’s t-test. Categor-
ical variables were compared using either the c2 or 
Fisher’s exact tests. A p value of less than 0.05 was 
considered statistically significant, whereas the con-
fidence intervals (CI) were 95%.
Results
After applying the inclusion and exclusion cri-
teria, the study covered 220 patients, in whom the 
total hip replacement procedure was performed. 
The mean age of the study population was 62.2 ± 
13.9 years and 42.7% of patients were male. The 
body mass index (BMI) in the study population 
was 27.0 ± 4.2 kg/m2. Detailed characteristics of the 
study population are listed in the Table I. Cardio-
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Table I. Baseline characteristics of the study population
Parameter Value
n = 220
Age (years) 62.2 ± 13.9
Male sex 94 (42.7%)
BMI [kg/m2] 27.0 ± 4.2
SBP [mm Hg] 134.5 ± 20.4
DBP [mm Hg] 78.6 ± 13.1
HR (beats per minute) 71.3 ± 14.0
Heart failure 10 (4.8%)
Diabetes mellitus 20 (9.1%)
Previously diagnosed arterial hypertension 128 (58.2%)
History of myocardial infarction 12 (5.5%)
History of stroke or TIA 2 (0.9%)
Peripheral artery disease 2 (0.9%)
Diagnosed dyslipidemia 8 (3.6%)
Stable coronary artery disease 22 (10.0%)
Blood pressure values > 140/90 mm Hg on 
admission
95 (43.2%)
Parameters are presented as mean ± standard deviation or n (%). 
BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic blood pressure; HR — he-
art rate; TIA — transient ischemic attack
vascular diseases and cardiovascular risk factors were 
not very frequent among the study population. Of 
the population, 58.2% of patients were diagnosed 
with arterial hypertension previously, 10% had di-
agnosed stable coronary artery disease, 5.5% and 
0.9% underwent myocardial infarction and stroke 
previously.
After taking blood pressure on admission, it was 
shown that mean systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) values were 134.5 ± 
20.4 and 78.6 ± 13.1 mm Hg, respectively (Figure 1). 
In 43.2% of patients the on admission blood pres-
sure values exceeded the threshold of ≥ 140 and/or 
90 mm Hg. Arterial hypertension was diagnosed de 
novo in 33 (15.0%) patients.
After dividing patients according to the presence 
of previously diagnosed arterial hypertension, it was 
found that patients with the disease were older (67.5 
± 12.3 vs. 54.4 ± 13.9 years; p < 0.0001), and had 
higher BMI (27.6 ± 4.3 vs. 26.2 ± 3.8 kg/m2; p = 
0.05) than patients without the diagnosed disease. 
Also, the prevalence of various comorbidities was 
significantly different between patients with and 
without previously diagnosed arterial hypertension. 
Diabetes mellitus was more often found in hyperten-
sive patients (13.3% vs. 3.3%; p = 0.02), they also 
more often had history of myocardial infarction (p = 
0.02) and stable coronary artery disease (p = 0.001) 
compared to patients without the diagnosis.
Figure 1. Mean blood pressure on admission
Interestingly, the SBP and DBP values were not 
significantly higher in patients with previously dia-
gnosed arterial hypertension (p > 0.05) than in those 
without the disease, but blood pressure values > 
140/90 mm Hg on admission were on the edge of 
statistical significance for being more prevalent in 
hypertensive patients (48.4% vs. 35.9%; p = 0.07). 
Detailed information on the group characteristics are 
presented in Table II.
Discussion
Total hip replacement is one of the orthopedic inter-
ventions associated with high thromboembolic risk and 
mortality rate. Perioperative cardiac events are a leading 
cause of death after non-cardiac surgery [7–9].
Singh et al. have described a population-based 
cohort of Olmsted County residents who underwent 
total hip arthroplasty between 1994 and 2008. Nine-
ty-day mortality in this group was 0.7%, throm-
boembolic events, including deep vein thrombosis 
and pulmonary embolism have been estimated on 
4% and 6.9% of population has manifested cardiac 
events (myocardial infarction, arrhythmia, congestive 
heart failure) [10].
In spite the fact that patients treated with total 
hip replacement have a lower comorbidity score than 
the whole arthritis population, they are at high risk 
for fatal complications [7]. Numerous high mor-
tality risk factors have been described and divided 
into modifiable and non-modifiable. The most im-
portant are associated with early 90-day mortality 
and include: fatal myocardial infarction, pulmonary 
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Table II. Patient characteristics according to the presence of previously diagnosed hypertension
Parameter Non-hypertensive patients
(n = 92)
Patients with previously 
diagnosed hypertension
(n = 128)
p value
Age (years) 54.4 ± 13.9 67.5 ± 12.3 < 0.0001
Male sex 45 (48.9%) 49 (38.3%) 0.13
BMI [kg/m2] 26.2 ± 3.8 27.6 ± 4.3 0.05
SBP [mm Hg] 130.6 ± 16.7 137.2 ± 16.7 0.07
DBP [mm Hg] 77.7 ± 10.9 79.2 ± 14.5 0.50
HR (beats per minute) 71.1 ± 13.7 71.5 ± 14.2 0.58
Heart failure 0 (0.0%) 10 (8.3%) 0.006
Diabetes mellitus 3 (3.3%) 17 (13.3%) 0.02
History of myocardial infarction 1 (1.1%) 11 (8.6%) 0.02
History of stroke or TIA 0 (0.0%) 2 (1.6%) 0.51
Peripheral artery disease 1 (1.1%) 1 (0.8%) 1.00
Diagnosed dyslipidemia 1 (1.1%) 7 (5.5%) 0.14
Stable coronary artery disease 2 (2.2%) 20 (15.6%) 0.001
Blood pressure values > 140/90 mm Hg on admission 33 (35.9%) 62 (48.4%) 0.07
Parameters are presented as mean ± standard deviation or n (%). 
BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic blood pressure; HR — heart rate; TIA — transient ischemic attack; AF — trial fibrillation
Figure 2. Prevalence of previously diagnosed arterial hypertension 
versus patients with blood pressure values meeting the criteria for 
hypertension diagnosis
BP — blood pressure, HT — arterial hypertension
embolism, postoperative hyperglycemia or elevated 
perioperative creatinine concentration [7, 8]. It is also 
confirmed that the elderly patients especially with his-
tory of dementia, preoperative anemia and prolonged 
hospital stay are more likely to die in the early post-
operative period [8]. However, total risk of serious 
complications after arthroplasty is not significantly 
high. Available literature reveals that thromboembolic 
complications such as venous thromboembolism and 
pulmonary embolism are classified as one of the most 
frequent, especially among elderly patients [6, 11].
For all these reasons it is important to estimate 
total cardiovascular and thromboembolic risk before 
surgery in order to reduce mortality in patients un-
dergoing hip replacement.
The thromboembolic risk stratification, especial-
ly important in prothrombotic states such as hip 
replacement, is currently facilitated with few popu-
lar risk assessment schemes. The most widely used, 
most of all in atrial fibrillation patients, but also 
acute coronary syndromes, pulmonary embolism or 
prediction of erectile dysfunction is the CHA2DS2-
-VASc score [12–14]. In the CHA2DS2-VASc score, 
as well as in other prediction schemes, the arterial 
hypertension is recognized as a thromboembolic risk 
factor [15]. Previous research suggests that hyperten-
sion is the most prevalent stroke risk factor (67.3%), 
followed by corona ry artery disease (38.4%). The sys-
tematic review emphasizes the importance of arterial 
hypertension, prior stroke/TIA, advancing age and 
diabetes as a stroke risk factors. On the other hand, 
vascular diseases, including myocardial infarction, 
peripheral artery disease, and complex aortic plaque 
increase TE risk in AF [15].
Therefore, in patients undergoing hip replace-
ment early diagnosis of arterial hypertension can 
help facilitate the decision on proper management 
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and suitable thromboembolic prophylaxis introduc-
tion. Assessment of the blood pressure values is im-
portant also for the preoperative and postoperative 
management outside of the coagulation control. It 
was observed that patient with untreated hyperten-
sion had greater decrease in blood pressure and were 
more exposed to myocardial infarction [16].
Hypertension undoubtedly correlates with higher 
perioperative risk leading to severe and minor com-
plications including: cardiovascular death, myocardi-
al infarction, heart failure, cerebrovascular accidents 
and perioperative tachycardia or bradycardia [16]. 
Moreover, labile blood pressure values may be strong-
ly associated with types of anesthetic drugs used in 
surgery procedure [16, 17]. Hypertensive patients 
seem to have higher cardiovascular lability during 
anesthesia due to increased systemic vascular resis-
tance [16, 18]. They are also more sensitive to intu-
bation and laryngoscopy during operation [16, 19]. 
All these factors have an effect on operation progress 
and perioperative complications risk. All hyperten-
sive patients should be treated appropriate prior to 
elective surgical procedure in order to avoid unwant-
ed events during and after surgery [16].
A new predictive model was recently developed 
to assess the risk of intra-operative/post-operative 
myocardial infarction or cardiac arrest, using the 
American College of Surgeons National Surgical 
Quality Improvement Program (NSQIP) database. 
The model incorporates risk factors, such as type 
of surgery, functional status, elevated creatinine 
(> 130 mmol/L or > 1.5 mg/dL), American Society 
of Anesthesiologists (ASA) class, age and is an easily 
applicable clinically based scheme [9, 20].
Also, current 2014 European Society of Cardiolo-
gy guidelines on cardiovascular assessment and man-
agement during non-cardiac surgery mention the 
significance of cardiovascular risk estimation prior to 
the procedure [20]. According to guidelines, clinical 
risk indices are recommended to be used for peri- 
-ope rative risk stratification. Effective strategies aimed 
at reducing the risk of perioperative cardiac compli-
cations should be considered for two reasons. Firstly, 
low-cardiac risk patients can be operated without 
further delay. Secondly, risk reduction by pharma-
cological treatment is most effective in patients with 
a suspected increased cardiac risk. Several risk indices 
have been developed during last 30 years [20].
Conclusions
Majority of patients scheduled for elective hip re-
placement surgery is diagnosed with arterial hyperten-
sion. Most of the patients have good blood pressure 
control, but in some cases, the disease is diagnosed de 
novo. Screening for arterial hypertension is important 
in this group of patients and can potentially reduce 
the complication rates of the hip replacement surgery.
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